Anand Patel
Child & Adolescent Psychiatry · Gainesville, FLNPI 1730475047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $346 and has fallen 81.2% since, to $65 in 2025.
Across 41 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$154
- Neurocrine Biosciences, Inc.$107
- Otsuka America Pharmaceutical, Inc.$105
- Ardelyx, Inc.$65
- Stryker$63
- Vanda Pharmaceuticals Inc.$62
- plus $284 from 9 others
Across 18 payments — averaging $34,782 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$626K
What the payments were for
- Food & beverage$841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 8 | $154 |
| Neurocrine Biosciences, Inc. | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Ardelyx, Inc. | 3 | $65 |
| Stryker | 1 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Alkermes, Inc. | 3 | $58 |
| Neos Therapeutics, LP | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $42 |
| Bausch Health US, LLC | 2 | $32 |
| Merck | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| AbbVie | 1 | $12 |
How this compares
$841 in reported general payments places this provider in the 60th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Gainesville
- Elias SarkisGainesville$169K
- Muhammad SajidGainesville$5K
- Ayesha LallGainesville$4K
- Amparo Benitez-BroomeGainesville$2K
- Craig KuninsGulfport$265K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.